Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Predicting psychiatric hospital admission among adults with schizophrenia.

Olfson M, Ascher-Svanum H, Faries DE, Marcus SC. Predicting psychiatric hospital admission among adults with schizophrenia. Psychiatric services (Washington, D.C.). 2011 Oct 1; 62(10):1138-45.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions



Abstract:

OBJECTIVE: The authors identified patient characteristics that increased risk of hospital admission among adults with schizophrenia. METHODS: A total of 1,460 participants in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) clinical trial were followed from the time they began a randomized trial of medication to first schizophrenia-related hospital admission. RESULTS: In 869 person-years of follow-up, 203 patients were hospitalized. Increased risk of hospital admission was associated with early age ( 17 years) of first antipsychotic treatment (adjusted hazard ratio [AHR] = 2.16, 95% confidence interval [CI] = 1.49-3.11), psychiatric hospitalization in past year (AHR = 2.99, CI = 2.23-4.00), having had DSM-IV alcohol (AHR = 1.56, CI = 1.16-2.10) or drug (AHR = 1.50, CI = 1.13-2.00) use disorders in the past five years, and baseline severe symptoms according to the Clinical Global Impressions Scale (AHR = 1.54, CI = 1.04-2.27), presence of tardive dyskinesia (AHR = 1.55, CI = 1.07-2.23), a high score on the positive symptoms subscale of the Positive and Negative Syndrome Scale (AHR = 1.52, CI = 1.07-2.15), and low social function (AHR = 1.45, CI = 1.03-2.04). As compared with olanzapine, the drugs quetiapine (AHR = 2.14, CI = 1.39-3.31), perphenazine (AHR = 1.80, CI = 1.11-2.94), and ziprasidone (AHR = 2.70, CI = 1.64-4.44) were associated with increased hospitalization risk. Risperidone was associated with a lower hospitalization risk than quetiapine (AHR = 1.50, CI = 1.01-2.22) and ziprasidone (AHR = 1.89, CI = 1.19-3.01). CONCLUSIONS: Efforts to lower hospital admission risk among individuals with schizophrenia should focus on history of early onset, recent inpatient admission, severe positive symptoms, poor social function, high global illness severity, and comorbid substance use disorders and on selection of an appropriate antipsychotic medication.





Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.